 This high-volume laboratory test will allow for collection of blood samples using a simplified proprietary blood collection device once cleared by the FDA. IRVINE, Calif., June 16, 2020 GLOBE NEWSWIRE -- Biomerica Inc. NASDAQ: BMRA announced today they have submitted to the FDA an EUA application for an ELISA lab-based serology blood test for the detection of antibodies that identify if a person has been infected with the novel coronavirus COVID-19. 